Page last updated: 2024-08-23

lovastatin and Obesity

lovastatin has been researched along with Obesity in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19902 (13.33)18.7374
1990's6 (40.00)18.2507
2000's2 (13.33)29.6817
2010's5 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christopher-Stine, L; Isackson, PJ; Kitzmiller, JP; Luzum, JA; Ma, C; Nguyen, LM; Ochs-Balcom, HM; Peltier, W; Tarnopolsky, M; Vladutiu, GD; Weisman, M; Wortmann, RL1
Choi, MS; Jeon, SM; Lee, SA1
Girotra, S; Mittleman, MA; Mukamal, KJ; Wee, CC; Weinstein, AR1
Correia, JF; de Oliveira, LF; Ferreira, EA; Filho, DW; Gris, EF; Pedrosa, RC; Rebello, JM1
Melone, M; Palyha, O; Rashid, S; Strack, A; Wilsie, L1
Hsu, YW; Lee, CL; Pan, TM; Wen, JY1
Jacobson, MS; Kohn, M1
Kasiske, BL; Keane, WF; Kim, Y; O'Donnell, MP; Schmitz, PG1
Bézard, J; Blond, JP; Georges, B; Maniongui, C1
Kuiper, JJ1
Mann, JI1
Bressler, P; DeFronzo, RA; Kudolo, GB1
Fuh, MM; Hung, YJ; Jeng, C; Kuo, SW; Pei, D; Wu, DA1
Cleary, MP; Kasiske, BL; Keane, WF; O'Donnell, MP1
Jurin, RR; McCune, SA1

Reviews

1 review(s) available for lovastatin and Obesity

ArticleYear
Cholesterol (and cardiovascular risk) in adolescence.
    Current opinion in pediatrics, 2004, Volume: 16, Issue:4

    Topics: Adolescent; Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Humans; Lovastatin; Obesity; Risk Factors; Simvastatin

2004

Trials

1 trial(s) available for lovastatin and Obesity

ArticleYear
The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy.
    Journal of the American College of Cardiology, 2008, Aug-19, Volume: 52, Issue:8

    Topics: Anticoagulants; Body Mass Index; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Obesity; Postoperative Period; Prognosis; Prospective Studies; Warfarin

2008

Other Studies

13 other study(ies) available for lovastatin and Obesity

ArticleYear
Clinical features related to statin-associated muscle symptoms.
    Muscle & nerve, 2019, Volume: 59, Issue:5

    Topics: Aged; Atorvastatin; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Logistic Models; Lovastatin; Male; Medical History Taking; Middle Aged; Muscle Weakness; Muscular Diseases; Myalgia; Obesity; Odds Ratio; Pravastatin; Retrospective Studies; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Smoking; White People

2019
Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice.
    Journal of medicinal food, 2014, Volume: 17, Issue:3

    Topics: Animals; Anti-Obesity Agents; Anticholesteremic Agents; Aorta; Apolipoproteins E; Arteriosclerosis; Diet, Atherogenic; Humans; Lovastatin; Male; Mice; Mice, Knockout; Obesity; Protective Agents; Resveratrol; Stilbenes

2014
The 2',4',6'-trihydroxyacetophenone isolated from Myrcia multiflora has antiobesity and mixed hypolipidemic effects with the reduction of lipid intestinal absorption.
    Planta medica, 2011, Volume: 77, Issue:14

    Topics: Acetophenones; Animals; Anti-Obesity Agents; Cholesterol; Diet, High-Fat; Glucosides; Hypolipidemic Agents; Intestinal Absorption; Lactones; Lipase; Lipids; Lovastatin; Male; Mice; Myrica; Obesity; Orlistat; Pancreas; Plant Extracts; Rats; Rats, Wistar; Triglycerides; Weight Gain

2011
Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin/kexin type 9.
    Journal of the American College of Cardiology, 2012, May-08, Volume: 59, Issue:19

    Topics: Dose-Response Relationship, Drug; Dyslipidemias; Hep G2 Cells; Hepatocytes; Humans; Immunoprecipitation; Lovastatin; Models, Biological; Obesity; Proprotein Convertases; Real-Time Polymerase Chain Reaction; Receptors, LDL; Resistin; RNA, Messenger; Subtilisin

2012
Monascus-fermented yellow pigments monascin and ankaflavin showed antiobesity effect via the suppression of differentiation and lipogenesis in obese rats fed a high-fat diet.
    Journal of agricultural and food chemistry, 2013, Feb-20, Volume: 61, Issue:7

    Topics: Adipocytes; Animals; Anti-Obesity Agents; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Creatine Kinase; Diet, High-Fat; Dose-Response Relationship, Drug; Fermentation; Flavins; Heterocyclic Compounds, 3-Ring; Lipogenesis; Lipolysis; Lovastatin; Male; Membrane Transport Proteins; Monascus; Obesity; PPAR gamma; Rats; Rats, Sprague-Dawley

2013
Lovastatin retards the progression of established glomerular disease in obese Zucker rats.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1993, Volume: 22, Issue:1

    Topics: Animals; Cell Division; Cells, Cultured; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Lovastatin; Male; Obesity; Rats; Rats, Zucker; Time Factors

1993
Effect of simvastatin on desaturase activities in liver from lean and obese Zucker rats.
    Lipids, 1993, Volume: 28, Issue:1

    Topics: Animals; Anticholesteremic Agents; Delta-5 Fatty Acid Desaturase; Fatty Acid Desaturases; Fatty Acids; Fatty Acids, Unsaturated; In Vitro Techniques; Linoleoyl-CoA Desaturase; Lovastatin; Male; Microsomes, Liver; Obesity; Phospholipids; Rats; Rats, Zucker; Simvastatin

1993
Effects of weight reduction and angiotensin-converting enzyme inhibition on IgA nephropathy-associated proteinuria.
    Nephron, 1996, Volume: 74, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Cholesterol; Diet, Reducing; Female; Glomerulonephritis, IGA; Hematuria; Humans; Lisinopril; Lovastatin; Middle Aged; Obesity; Proteinuria; Weight Loss

1996
The role of nutritional modifications in the prevention of macrovascular complications of diabetes.
    Diabetes, 1997, Volume: 46 Suppl 2

    Topics: Antioxidants; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diet Therapy; Energy Intake; Energy Metabolism; Humans; Lovastatin; Minerals; Obesity; Simvastatin; Vitamins

1997
Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment.
    Journal of lipid mediators and cell signalling, 1997, Volume: 17, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Lovastatin; Male; Middle Aged; Obesity; Phospholipases A

1997
Effects of lovastatin and gemfibrozil in subjects with high ratios of total cholesterol to high-density lipoprotein cholesterol.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 1999, Volume: 98, Issue:2

    Topics: Adult; Aged; Anticholesteremic Agents; Blood Glucose; Cholesterol; Cholesterol, HDL; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin; Leptin; Lovastatin; Male; Middle Aged; Obesity; Proteins

1999
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats.
    Kidney international, 1988, Volume: 33, Issue:3

    Topics: Albuminuria; Animals; Cholesterol; Clofibrate; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Lovastatin; Male; Obesity; Rats; Rats, Zucker; Triglycerides

1988
Effect of mevinolin on cholesterol metabolism in obese and lean Zucker rats.
    Biochemical pharmacology, 1987, Mar-15, Volume: 36, Issue:6

    Topics: Animals; Blood Glucose; Cholesterol; Female; Liver; Lovastatin; Naphthalenes; Obesity; Rats; Rats, Zucker; Triglycerides

1987